More Clinical Trial Results for Mucosal Covid Vaccines (NextGen Vax Update 31)

['Hilda Bastian', '.Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow', 'Class', 'Wp-Block-Co-Authors-Plus', 'Display Inline', '.Wp-Block-Co-Authors-Plus-Avatar', 'Where Img', 'Height Auto Max-Width', 'Vertical-Align Bottom .Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow .Wp-Block-Co-Authors-Plus-Avatar', 'Vertical-Align Middle .Wp-Block-Co-Authors-Plus-Avatar Is .Alignleft .Alignright'] Absolutely Maybe 2025-07-30 00:00:00

Phase 1 trial results for intranasal viral vector vaccine, CVXGA1 (CyanVac/Blue Lake Biotech, USA)This is an intranasal viral vector vaccine, based on parainfluenza 5 (PIV5). 34 mucosal vaccines have reached clinical trial, although some of the vaccines are no longer in development. Back to contentsAddendum 1: List of authorized next generation Covid vaccines (with countries)There are now 7 next-generation Covid vaccines authorized in 7 countries. Self-amplifying mRNA:Back to contentsAddendum 2: Table of mucosal vaccines in clinical trials* Indicates new entry since previous update post. Previous update posts specifically on next generation Covid vaccines prior to this monthly series (beginning May 2023):All my posts on Covid vaccines, beginning from March 2020, are tagged here.